Literature DB >> 11728823

Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells.

L H Jin1, J H Bahn, W S Eum, H Y Kwon, S H Jang, K H Han, T C Kang, M H Won, J H Kang, S W Cho, J Park, S Y Choi.   

Abstract

Antioxidant enzymes such as superoxide dismutase (SOD) and catalase (CAT) have been considered to have a beneficial effect against various diseases mediated by reactive oxygen species (ROS). Although a variety of modified recombinant antioxidant enzymes have been generated to protect against the oxidative stresses, the lack of their transduction ability into cells resulted in limited ability to detoxify intracellular ROS. To render the catalase enzyme capable of detoxifying intracellular ROS when added extracellularly, cell-permeable recombinant catalase proteins were generated. A human liver catalase gene was cloned and fused with a gene fragment encoding the HIV-1 Tat protein transduction domain (RKKRRQRRR) and arginine-rich peptides (RRRRRRRRR) in a bacterial expression vector to produce genetic in-frame Tat-CAT and 9Arg-CAT fusion proteins, respectively. The expressed and purified fusion proteins can be transduced into mammalian cells (HeLa and PC12 cells) in a time- and dose-dependent manner when added exogenously in culture medium, and transduced fusion proteins were enzymatically active and stable for 60 h. When exposed to H(2)O(2), the viability of HeLa cells transduced with Tat-CAT or 9Arg-CAT fusion proteins was significantly increased. In combination with transduced SOD, transduced catalase also resulted in a cooperative increase in cell viability when the cells were treated with paraquat, an intracellular antioxide anion generator. We then evaluated the ability of the catalase fusion proteins to transduce into animal skin. This analysis showed that Tat-CAT and 9Arg-CAT fusion proteins efficiently penetrated the epidermis as well as the dermis of the subcutaneous layer when sprayed on animal skin, as judged by immunohistochemistry and specific enzyme activities. These results suggest that Tat-CAT and 9Arg-CAT fusion proteins can be used in protein therapy for various disorders related to this antioxidant enzyme.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11728823     DOI: 10.1016/s0891-5849(01)00734-1

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  27 in total

Review 1.  Development of mitochondrial gene replacement therapy.

Authors:  Shaharyar M Khan; James P Bennett
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

2.  Chimeric p53 as an alternative therapy for hypoxic tumors.

Authors:  Jun-Ho Lee; Hua Lu
Journal:  Cancer Biol Ther       Date:  2011-01-01       Impact factor: 4.742

3.  Endothelial targeting of antibody-decorated polymeric filomicelles.

Authors:  Vladimir V Shuvaev; Marc A Ilies; Eric Simone; Sergei Zaitsev; Younghoon Kim; Shenshen Cai; Abdullah Mahmud; Thomas Dziubla; Silvia Muro; Dennis E Discher; Vladimir R Muzykantov
Journal:  ACS Nano       Date:  2011-08-23       Impact factor: 15.881

4.  Characterisation of cell-penetrating peptide-mediated peptide delivery.

Authors:  Simon W Jones; Richard Christison; Ken Bundell; Catherine J Voyce; Sarah M V Brockbank; Peter Newham; Mark A Lindsay
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

5.  The transduction of His-TAT-p53 fusion protein into the human osteogenic sarcoma cell line (Saos-2) and its influence on cell cycle arrest and apoptosis.

Authors:  Lei Jiang; Yushu Ma; Jinzhi Wang; Xinyi Tao; Dongzhi Wei
Journal:  Mol Biol Rep       Date:  2007-01-06       Impact factor: 2.316

Review 6.  Targeting therapeutics to endothelium: are we there yet?

Authors:  Raisa Yu Kiseleva; Patrick M Glassman; Colin F Greineder; Elizabeth D Hood; Vladimir V Shuvaev; Vladimir R Muzykantov
Journal:  Drug Deliv Transl Res       Date:  2018-08       Impact factor: 4.617

7.  Reprogramming human fibroblasts using HIV-1 TAT recombinant proteins OCT4, SOX2, KLF4 and c-MYC.

Authors:  Chuanying Pan; Baisong Lu; Hong Chen; Colin E Bishop
Journal:  Mol Biol Rep       Date:  2009-08-09       Impact factor: 2.316

8.  Targeted modulation of reactive oxygen species in the vascular endothelium.

Authors:  Vladimir V Shuvaev; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2011-03-30       Impact factor: 9.776

9.  Study on characteristics of in vitro culture and intracellular transduction of exogenous proteins in fibroblast cell line of Liaoning cashmere goat.

Authors:  P F Hu; W J Guan; X C Li; W X Zhang; C L Li; Y H Ma
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

Review 10.  Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery.

Authors:  Pinaki Desai; Ram R Patlolla; Mandip Singh
Journal:  Mol Membr Biol       Date:  2010-10       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.